Neogenomics (NEO) PT Raised to $13 at Jefferies
Tweet
Share
E-mail
Get Alerts NEO Hot Sheet
Price: $16.53 -0.6%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Jefferies analyst Tycho Peterson raised the price target on Neogenomics (NASDAQ: NEO) to $13.00 (from $7.50) while maintaining a Buy rating.
The analyst comments "NEO posted a modest beat (+2%), underpinned by solid clinical and NGS momentum, which is a constructive pivot following back-to-back misses. FY25 guidance was reaffirmed. Looking to 2026, we see a favorable setup, aided by MRD expansion (sign up for our upcoming MRD call here), the PanTracer LBx rollout, and operational streamlining as key growth levers. Reiterate Buy. "
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Gap, Inc. (GAP) to Hold
- JPMorgan Upgrades JOYY (JOYY) to Overweight
- Barclays Upgrades Akzo Nobel NV (AKZA:NA) (AKZOY) to Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Jefferies & Co, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
